1995
DOI: 10.1002/jmri.1880050108
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative mr imaging data in the evaluation of hepatic metastases during systemic chemotherapy

Abstract: To identify changes induced by chemotherapy in hepatic metastases, 34 patients with metastases underwent magnetic resonance (MR) imaging before the start of systemic chemotherapy and monthly thereafter. The number, size, and morphologic patterns of the lesions and changes in quantitative parameters (signal-to-noise ratio [S/N]], contrast-to-noise ratio, and signal intensity ratio) were evaluated and correlated with response to treatment and prognosis. After treatment, seven patients showed a partial response, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1996
1996
2015
2015

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 25 publications
0
4
0
Order By: Relevance
“…Transient perilesional hepatic parenchymal enhancement may also be observed in metastases and lymphoma (13,16). The distinction from cystic metastases (eg, ovarian cancer) or chemotherapy-treated metastases that become centrally necrotic may be morphologically more difficult (17,18). In these cases the clinical history is particularly useful.…”
Section: Discussionmentioning
confidence: 99%
“…Transient perilesional hepatic parenchymal enhancement may also be observed in metastases and lymphoma (13,16). The distinction from cystic metastases (eg, ovarian cancer) or chemotherapy-treated metastases that become centrally necrotic may be morphologically more difficult (17,18). In these cases the clinical history is particularly useful.…”
Section: Discussionmentioning
confidence: 99%
“…Chemotherapy-induced changes result in alterations of signal intensity on T1and T2-weighted images of metastases so that they approach the signal intensity of liver. 32,33 Chemotherapytreated metastases also may develop an appearance that resembles cysts, hemangiomas, or scar tissue. 34 As mentioned earlier, they also may become near isovascular on postgadolinium images.…”
Section: Hepatic Arterial Dominant Phasementioning
confidence: 99%
“…More recently, gadolinium‐based contrast agents have been engineered with diverse physical–chemical properties to encourage tissue specific accumulation. Biodistribution can be manipulated by either directly altering the chemical properties of the Gd‐chelate, e.g., by incorporating a lipophilic moiety or by coupling chelated Gd to macromolecules or nanoparticles; water‐soluble Gd‐complexes with a lipophilic moiety exhibit enhanced hepatic uptake 11–15. Gd‐labeled (or loaded) nanoparticles have garnered a particularly high degree of interest.…”
Section: Introductionmentioning
confidence: 99%